Literature DB >> 23104758

Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa.

C J Hoffmann1, D Dayal, M Cheyip, J A McIntyre, G E Gray, S Conway, N A Martinson.   

Abstract

We assessed prevalence and factors associated with hepatitis B in a cross section of HIV-infected primary care and antinatal clinic patients in South Africa and evaluated a rapid hepatitis B surface antigen (HBsAg) assay. We enrolled 998 patients; 88% were women, median age was 29 years and median CD4 count was 354 cells/mm(3). HBsAg enzyme-linked immunosorbent assay (ELISA), anti-hepatitis B core (HBc) antibodies and hepatitis C virus antibody were positive among 4.2%, 37% and 0.1% of subjects, respectively. Univariate and multivariate associations were assessed using logistic regression. Anti-HBc antibodies were associated with alcohol use, traditional medicines and higher CD4 counts; HBsAg positivity was associated with lower CD4. Compared with the HBsAg ELISA, a rapid HBsAg test had a sensitivity of 75.0% and specificity of 99.6%. In conclusion, we identified a moderate prevalence of both HBsAg and anti-HBc. Importantly, we found that subjects with HBsAg positivity had lower CD4 counts.

Entities:  

Mesh:

Year:  2012        PMID: 23104758      PMCID: PMC3724418          DOI: 10.1258/ijsa.2009.009340

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  25 in total

1.  Preimmunization epidemiology of hepatitis B virus infection in South African children.

Authors:  E Vardas; M Mathai; D Blaauw; J McAnerney; A Coppin; J Sim
Journal:  J Med Virol       Date:  1999-06       Impact factor: 2.327

2.  Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana.

Authors:  F E Martinson; K A Weigle; R A Royce; D J Weber; C M Suchindran; S M Lemon
Journal:  Am J Epidemiol       Date:  1998-03-01       Impact factor: 4.897

3.  HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.

Authors:  François Rouet; Marie-Laure Chaix; André Inwoley; Philippe Msellati; Ida Viho; Patrice Combe; Valériane Leroy; François Dabis; Christine Rouzioux
Journal:  J Med Virol       Date:  2004-09       Impact factor: 2.327

4.  Reactivation of hepatitis B.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study.

Authors:  Saidi Kapiga; Cliff Kelly; Stephen Weiss; Tara Daley; Leigh Peterson; Corey Leburg; Gita Ramjee
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

6.  Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa.

Authors:  S S Abdool Karim; R Thejpal; H M Coovadia
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

7.  Alcohol abuse, sexual risk behaviors, and sexually transmitted infections in women in Moshi urban district, northern Tanzania.

Authors:  Musie Ghebremichael; Elijah Paintsil; Ulla Larsen
Journal:  Sex Transm Dis       Date:  2009-02       Impact factor: 2.830

Review 8.  Clinical implications of HIV and hepatitis B co-infection in Asia and Africa.

Authors:  Christopher J Hoffmann; Chloe L Thio
Journal:  Lancet Infect Dis       Date:  2007-06       Impact factor: 25.071

9.  Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.

Authors:  M Nyirenda; M B J Beadsworth; P Stephany; C A Hart; I J Hart; C Munthali; N J Beeching; E E Zijlstra
Journal:  J Infect       Date:  2008-06-13       Impact factor: 6.072

10.  Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.

Authors:  Christopher J Hoffmann; Salome Charalambous; Desmond J Martin; Craig Innes; Gavin J Churchyard; Richard E Chaisson; Alison D Grant; Katherine L Fielding; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

View more
  12 in total

1.  Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.

Authors:  Caroline C Chisenga; Kalo Musukuma; Roma Chilengi; Samuel Zürcher; Virginia Munamunungu; Alice Siyunda; David Ojok; Sophie Bauer; Gilles Wandeler; Michael Vinikoor
Journal:  J Clin Virol       Date:  2017-11-16       Impact factor: 3.168

Review 2.  HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.

Authors:  Kasha P Singh; Megan Crane; Jennifer Audsley; Anchalee Avihingsanon; Joe Sasadeusz; Sharon R Lewin
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

3.  Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

Authors:  Harr Freeya Njai; Yusuke Shimakawa; Bakary Sanneh; Lynne Ferguson; Gibril Ndow; Maimuna Mendy; Amina Sow; Gora Lo; Coumba Toure-Kane; Junko Tanaka; Makie Taal; Umberto D'alessandro; Ramou Njie; Mark Thursz; Maud Lemoine
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

4.  Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.

Authors:  Christopher J Hoffmann; Fildah Mashabela; Silvia Cohn; Jennifer D Hoffmann; Sanjay Lala; Neil A Martinson; Richard E Chaisson
Journal:  J Int AIDS Soc       Date:  2014-05-22       Impact factor: 5.396

5.  Real-time polymerase chain reaction optimised for hepatitis C virus detection in dried blood spots from HIV-exposed infants, KwaZulu-Natal, South Africa.

Authors:  Anneta Naidoo; Raveen Parboosing; Pravi Moodley
Journal:  Afr J Lab Med       Date:  2016-03-18

6.  Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

Authors:  Motswedi Anderson; Simani Gaseitsiwe; Sikhulile Moyo; Kerapetse P Thami; Terence Mohammed; Ditiro Setlhare; Theresa K Sebunya; Eleanor A Powell; Joseph Makhema; Jason T Blackard; Richard Marlink; Max Essex; Rosemary M Musonda
Journal:  Open Forum Infect Dis       Date:  2016-08-16       Impact factor: 3.835

7.  Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.

Authors:  Adrià Ramírez-Mena; Tracy R Glass; Annja Winter; Namvua Kimera; Alex Ntamatungiro; Christoph Hatz; Marcel Tanner; Manuel Battegay; Hansjakob Furrer; Gilles Wandeler; Emilio Letang
Journal:  Open Forum Infect Dis       Date:  2016-07-29       Impact factor: 3.835

Review 8.  Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis.

Authors:  Ali Amini; Olivia Varsaneux; Helen Kelly; Weiming Tang; Wen Chen; Debrah I Boeras; Jane Falconer; Joseph D Tucker; Roger Chou; Azumi Ishizaki; Philippa Easterbrook; Rosanna W Peeling
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

9.  Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.

Authors:  Nishi Prabdial-Sing; Lillian Makhathini; Sheilagh Brigitte Smit; Morubula Jack Manamela; Nkengafac Villyen Motaze; Cheryl Cohen; Melinda Shelley Suchard
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

10.  Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania.

Authors:  Fabian C Franzeck; Ramadhani Ngwale; Bernadeta Msongole; Marian Hamisi; Omary Abdul; Lars Henning; Emilio Letang; Geoffrey Mwaigomole; Manuel Battegay; Christoph Hatz; Marcel Tanner
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.